N Sedransk - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

N Sedransk

Showing results (21-30 of 24) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 24 results.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001

Phase I clinical and pharmacokinetic study of rebeccamycin analog NSC 655649 given daily for five consecutive daysA Dowlati, C L Hoppel, S T Ingalls, et al.

Annals of Surgery|January 1, 1984

Reversal of fibronectin and opsonic deficiency in patients. A controlled studyT M Saba, F A Blumenstock, D M Shah, et al.

Journal of Medicinal Chemistry|May 1, 1982

Agents for the treatment of brain injury. 1. (Aryloxy)alkanoic acidsE J Cragoe, N P Gould, O W Woltersdorf, et al.

Drugs|March 11, 2000

Oral combination chemotherapy in the management of AIDS-related lymphoproliferative malignanciesS C Remick, N Sedransk, R Haase, et al.

Pageof 3

Search research articles

Showing results (21-30 of 24) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 24 results.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001

Phase I clinical and pharmacokinetic study of rebeccamycin analog NSC 655649 given daily for five consecutive daysA Dowlati, C L Hoppel, S T Ingalls, et al.

Annals of Surgery|January 1, 1984

Reversal of fibronectin and opsonic deficiency in patients. A controlled studyT M Saba, F A Blumenstock, D M Shah, et al.

Journal of Medicinal Chemistry|May 1, 1982

Agents for the treatment of brain injury. 1. (Aryloxy)alkanoic acidsE J Cragoe, N P Gould, O W Woltersdorf, et al.

Drugs|March 11, 2000

Oral combination chemotherapy in the management of AIDS-related lymphoproliferative malignanciesS C Remick, N Sedransk, R Haase, et al.

Pageof 3